However, you must consult your healthcare provider before stopping to ensure alternative diabetes management is in place and to prevent blood glucose deterioration
That's the short answer to why tirzepatide works when semaglutide doesn't for a meaningful share of patients
Storage: Store refrigerated prior to initial use
Can it be sold for research
The compounded medication distinction is real and important - these products lack the FDA review that branded alternatives have undergone, and you should be fully comfortable with this after your own research and physician consultation
As Dr Sullivan commented, the benefit appears to increase over time rather than fade, and that it behaves like a drug in terms of dose response. Dr Sullivan and colleagues concluded that these results support DMR as a promising, procedure-based strategy to maintain weight loss and potentially enable shorter-duration GLP-1 therapy. In a press release, Dr Sullivan noted, Finding a treatment that allows patients to stop [GLP-1] medications without weight regain or loss of metabolic benefit is a huge unmet need. She continued, These findings indicate that this minimally invasive procedure may provide lasting weight-loss maintenance. Six-month cohort data from the REMAIN-1 trial are expected to be reported late in 2026.